Sg3 Management, LLC Profound Medical Corp. Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $510,000 - $670,500	-37,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.0 - $20.59 $120,000 - $154,425	7,500 Added 25.0%	37,500 $614,000
Q1 2021 May 17, 2021	SELL	$19.16 - $28.09 $19,160 - $28,090	-1,000 Reduced 3.23%	30,000 $604,000
Q4 2020 Feb 16, 2021	BUY	$16.4 - $22.9 $287,328 - $401,208	17,520 Added 129.97%	31,000 $637,000
Q3 2020 Nov 13, 2020	BUY	$14.05 - $18.13 $189,394 - $244,392	13,480 New	13,480 $238,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.